| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/24/2012 | CA2508763C Human antibody producing mouse and method for producing human antibody using the same |
| 01/24/2012 | CA2492848C Isolation and identification of t cells |
| 01/24/2012 | CA2480567C Mixed-cell gene therapy |
| 01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
| 01/24/2012 | CA2461647C Lysin-deficient bacteriophages having reduced immunogenicity |
| 01/24/2012 | CA2460206C Method for production of recombinant proteins in eukaryote cells |
| 01/24/2012 | CA2456055C Microoroganisms and cells for diagnosis and therapy of tumors |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2439428C Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/24/2012 | CA2438935C Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 01/24/2012 | CA2436754C Production of a monoclonal antibody by a transgenic avian |
| 01/24/2012 | CA2425747C Solid support assay systems and methods utilizing non-standard bases |
| 01/24/2012 | CA2416632C Novel starches produced by the expression of heterologous granule bound starch synthase genes |
| 01/24/2012 | CA2410828C Duplexed parvovirus vectors |
| 01/24/2012 | CA2406388C Control of fruit dehiscence in arabidopsis by indehiscent1 genes |
| 01/24/2012 | CA2406168C Polyamide nucleic acid derivatives, agents and methods for producing same |
| 01/24/2012 | CA2399281C Method for detecting cytosine methylation in dna samples |
| 01/24/2012 | CA2390049C Control of post-transcriptional gene silencing in plants |
| 01/24/2012 | CA2386920C Oncolytic virus |
| 01/24/2012 | CA2382290C Gene regulating plant branching, vector containing the gene, microorganism transformed by the vector, and method for regulating plant branching by using the microorganism |
| 01/24/2012 | CA2378802C Inactivated vaccine against feline calicivirus disease |
| 01/24/2012 | CA2375263C Method for conducting chemiluminescent binding assay |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2370132C Auxin transport proteins |
| 01/24/2012 | CA2330024C Polyunsaturated fatty acids in plants |
| 01/24/2012 | CA2327350C Bacillus thuringiensis toxins and genes for controlling coleopteran pests |
| 01/24/2012 | CA2310454C Protease variants and compositions |
| 01/24/2012 | CA2298841C Methods and reagents for preserving rna in cell and tissue samples |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/24/2012 | CA2274987C Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 01/24/2012 | CA2269204C Anti-erbb2 antibodies |
| 01/24/2012 | CA2260754C Novel vegf-like factor |
| 01/24/2012 | CA2221318C High affinity oligonucleotide ligands to growth factors |
| 01/19/2012 | WO2012009711A2 Retrovirus detection |
| 01/19/2012 | WO2012009667A2 Targeted 2'-o-methylation of telomerase non-coding rna |
| 01/19/2012 | WO2012009648A2 Novel nitrate reductase fusion proteins and uses thereof |
| 01/19/2012 | WO2012009644A2 Methods to identify synthetic and natural rna elements that enhance protein translation |
| 01/19/2012 | WO2012009551A1 Promoter, promoter control elements, and combinations, and uses thereof |
| 01/19/2012 | WO2012009508A2 Microrna compositions and methods related thereto |
| 01/19/2012 | WO2012009499A2 Assessing thyroid neoplasms and treating cancer |
| 01/19/2012 | WO2012009447A2 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF |
| 01/19/2012 | WO2012009402A2 Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg |
| 01/19/2012 | WO2012009347A2 Treatment of bcl2 binding component 3 (bbc3) related diseases by inhibition of natural antisense transcript to bbc3 |
| 01/19/2012 | WO2012009206A2 Sequencing reactions with alkali metal cations for pulse width control |
| 01/19/2012 | WO2012008831A1 Simplified de novo physical map generation from clone libraries |
| 01/19/2012 | WO2012008810A2 Microorganism with enhanced l-lysine productivity and method for producing l-lysine using the same |
| 01/19/2012 | WO2012008809A2 Microorganism having improved l-ornithine productivity, and method for producing l-ornithine using same |
| 01/19/2012 | WO2012008807A2 Use of tgase2 and vhl as a diagnostic marker for renal cell carcinoma |
| 01/19/2012 | WO2012008768A2 Method for preparing transformed potato plants having multispecies virus resistance, and potato plants prepared by same |
| 01/19/2012 | WO2012008748A2 Mannose 6-phosphate isomerase mutant derived from geobacillus thermodenitrificans, and production method of l-ribose using same |
| 01/19/2012 | WO2012008746A2 Dna double helical structure model |
| 01/19/2012 | WO2012008595A1 Method for producing anti-lr11 antibody and standard for immunoassay |
| 01/19/2012 | WO2012008585A1 Novel lactobacillus and method for producing l-lactic acid using same |
| 01/19/2012 | WO2012008584A1 Method for creating antibodies, and antibodies |
| 01/19/2012 | WO2012008581A1 Holder that holds identifying information for identifying an identification subject, and use therefor |
| 01/19/2012 | WO2012008494A1 Uterine cancer test method, uterine cancer test drug, and antibody for uterine cancer antigen |
| 01/19/2012 | WO2012008465A1 (nucleic acid)-polysaccharide complex |
| 01/19/2012 | WO2012008407A1 Microinjection device |
| 01/19/2012 | WO2012008397A1 Anti-epha2 antibody and use thereof |
| 01/19/2012 | WO2012008361A1 Method for introducing nucleic acid to cell and nucleic acid complex |
| 01/19/2012 | WO2012008302A1 Method for preparing novel hipsc by means of mirna introduction |
| 01/19/2012 | WO2012008301A1 Method for producing novel hipsc by means of sirna introduction |
| 01/19/2012 | WO2012008298A1 Isoprene oligomer, polyisoprene, processes for producing these materials, rubber composition, and pneumatic tire |
| 01/19/2012 | WO2012008023A1 Mutant polyhydroxyalkanoic acid synthase gene and method for producing aliphatic polyester using same |
| 01/19/2012 | WO2012007965A1 Enzyme for the production of optically pure 3 - quinuclidinol |
| 01/19/2012 | WO2012007951A1 Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides |
| 01/19/2012 | WO2012007919A2 Nucleic acid construct for increasing abiotic stress tolerance in plants |
| 01/19/2012 | WO2012007916A2 Plants having enhanced yield-related traits and a method for making the same |
| 01/19/2012 | WO2012007646A1 Microorganisms with extended substrate utilization range |
| 01/19/2012 | WO2012007587A1 Methods for producing proteins in plants |
| 01/19/2012 | WO2012007582A1 Method for rapidly providing constituents from biological samples |
| 01/19/2012 | WO2012007581A1 Method of concentrating bacteria, viruses and cells and for the subsequent isolation of nucleic acid |
| 01/19/2012 | WO2012007569A1 Method for purifying a target nucleic acid |
| 01/19/2012 | WO2012007548A1 (r)-selective amination |
| 01/19/2012 | WO2012007481A2 Metabolically engineered organisms for the production of added value bio-products |
| 01/19/2012 | WO2012007477A1 Anti hcv oligomers |
| 01/19/2012 | WO2012007458A1 Gene therapy composition for use in diabetes treatment |
| 01/19/2012 | WO2012007117A1 Method for the isolation of proteins binding to any kind nucleic acid sequence of interest |
| 01/19/2012 | WO2012006962A1 Truncated human papillomavirus type 58 l1 protein |
| 01/19/2012 | WO2012006866A1 BOTANICAL YELLOW DWARF DISEASE RESISTANT PROTEIN TiSTKI, CODING GENE AND APPLICATION THEREOF |
| 01/19/2012 | WO2012006732A1 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction |
| 01/19/2012 | WO2012006730A1 Diagnostic method for colitis |
| 01/19/2012 | WO2012006727A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 01/19/2012 | WO2011154710A3 Optical transfection |
| 01/19/2012 | WO2011153493A3 Biodegradable lipids for the delivery of active agents |
| 01/19/2012 | WO2011152722A3 Cloning and exploitation of a functional r-gene from solanum x edinense |
| 01/19/2012 | WO2011150421A3 Recombinant bacterium to decrease tumor growth |
| 01/19/2012 | WO2011147590A3 Tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains |
| 01/19/2012 | WO2011143323A3 Programmable self-assembled nanostructures based on sidechain-modified pna for the multivalent display of ligands |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011127088A3 Methods and compositions for decreasing chronic pain |
| 01/19/2012 | WO2011126644A3 Plant peptide gamma-zein for delivery of biomolecules into plant cells |
| 01/19/2012 | WO2011123708A3 Genetic engineering of non-human animals for the production of chimeric antibodies |
| 01/19/2012 | WO2011119507A3 Method of altering the differentiative state of a cell and compositions thereof |
| 01/19/2012 | WO2011116383A3 Compositions and methods for material transfer into cells |
| 01/19/2012 | WO2011116358A3 Microorganisms with inactivated lactate dehydrogenase gene (ldh) for chemical production |
| 01/19/2012 | WO2011115975A3 Use of achromopeptidase for lysis at room temperature |
| 01/19/2012 | WO2011112980A9 Innate immunity markers of cancer |
| 01/19/2012 | WO2011112915A3 Methods and compositions containing fc fusiong proteins for enhancing immune responses |
| 01/19/2012 | WO2011112903A3 Quantitative rt-pcr detection for genes involved in epithelial mesenchymal transition in peripheral blood of breast cancer patients |